|
|
Science Sparks @ ACTREC
|
27th June 2022 |
Vol. No. 11; Issue No. 532 |
|
Publications
|
1. Murthy V, Adsul K, Maitre P, Singhla A, Singh P, Panigrahi G, Raveendran V, Phurailatpam R (2022). Acute and late toxicity of prostate-only or pelvic SBRT in prostate cancer: A Comparative study. International Journal of Radiation Oncology,Biology,Physics.
2. Joshi K, Joshi P, Nair S, Chaturvedi P (2022). Submandibular gland in squamous cell carcinoma of the tongue: Can preservation during neck dissection be a pragmatic option? Journal of Cancer Research and Therapeutics.
3. Sali AP, Prakash G, Murthy V, Joshi A, Shah A, Desai SB, Menon S (2022). Updates in staging of penile cancer: The evolution, nuances, and issues. Human Pathology.
4. Menon N, Patil V, Ramaswamy A, Gattani S, Castelino R, Dhekale R, Gota V, Sekar A, Deodhar J, Mahajan S, Daptardar A, Prabhash K, Banavali S, Badwe R, Noronha V (2022). Caregiver burden in older Indian patients with cancer- Experience from a tertiary care center. Journal of Geriatric Oncology.
5. Chaudhary N, Joshi N, Doloi R, Shivashankar A, Thorat R, Dalal S (2022). Plakophilin3 loss leads to an increase in autophagy and radio-resistance. Biochemical and Biophysical Research Communications.
6. Khoury JD, Solary E, Abla O ,... Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Khattry N, Subramanian PG. et al. (2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic/dendritic neoplasms. Leukemia.
7. Alaggio R, Amador C, Anagnostopoulos I,... Laskar S, Tembhare P. et al.(2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid neoplasms. Leukemia.
Book Chapter Mehta D, Waghmare SK. (2022) "Emerging Metabolic Regulation of Redox Status in Cancer Stem Cells Progression and Metastasis". In: Chakraborti S. (Ed.) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Singapore; Springer.
|
|
|
Interesting Reads
|
Diamantopoulou Z, Castro-Giner F, Schwab FD, Foerster C, Saini M, Budinjas S, Strittmatter K, Krol I, Seifert B, Heinzelmann-Schwarz V, Kurzeder C, Rochlitz C, Vetter M, Weber WP, Aceto N. The metastatic spread of breast cancer accelerates during sleep. Nature, 2022.
|
|
Legends of Science
|
|
Alok Bhattacharya
Alok Bhattacharya earned his Ph.D. from Jawaharlal Nehru University in 1976. His research area includes parasitology, computation biology, and bioinformatics. He extensively worked in the areas of molecular and genomic studies on the protozoan parasite, entamoeba histolytica, the causative agent of amoebiasis. Dr. Bhattacharya was the recipient of the Shanti Swarup Bhatnagar Award in 1994. He is an elected fellow of the Indian National Science Academy and the Indian Academy of Sciences; and J.C. Bose National Fellow.
|
|
|
|
Raghuram Varadarajan
Raghuram Varadarajan obtained his Ph.D. from Stanford University. He developed a new crystallographic and Nuclear Magnetic resonance hydrogen exchange protocol for the characterization of disordered states of proteins. His team developed several immunogens which demonstrated positive effects as HIV-1 vaccines. Dr. Varadarajan was elected by the Indian Academy of Sciences, Bengaluru. He received the AIDS-Innovation Grant Award by NIH, USA, in 1999 and the SS Bhatnagar award in 2002.
|
|
|
|
|
Do You Know?
In 2012, Adaptive radiation therapy, a type of image-guided radiation therapy that allows radiation oncologists to replan and optimise the treatment during the course, was introduced.
|
|
|
Cancer News
|
New model helps identify mutations that drive cancer
|
20 June 2022, MIT News
|
The researchers found additional mutations across the genome that appear to contribute to tumor growth in 5 to 10 percent of cancer patients. The findings could help doctors to identify drugs that would have greater chance of successfully treating those patients...
|
|
|
|
|
|
Researchers develop blood test to predict liver cancer risk
|
22 June 2022, MedicalXpress
|
The researchers showed that levels of the molecules changed in conjunction with therapies known to decrease liver inflammation and HCC risk, including bariatric surgery, cholesterol drugs, and an immunotherapy... |
|
|
|
|
|
|
� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|